Chemical Structure : IMMH-010
Catalog No.: PC-20281Not For Human Use, Lab Use Only.
IMMH-010 (YPD-30) is an ester prodrug of YPD-29B, a high potent PD-L1 inhibitor (IC50=0.08 pM), YPD-30 is a potent PD-L1 inhibitor with IC50 of 45.2 nM in HTRF assays.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IMMH-010 (YPD-30) is an ester prodrug of YPD-29B, a high potent PD-L1 inhibitor (IC50=0.08 pM), YPD-30 is a potent PD-L1 inhibitor with IC50 of 45.2 nM in HTRF assays.
YPD-30 is an orally bioavailable prodrug for YPD-29B with significantly higher bioavailability than YPD-29B.
YPD-30 exhibits antitumor activity by inhibiting PD-L1 in vivo, significantly increased T cell infiltration by increasing CD3 and CD8 expression in hPD-L1 MC38 xenograft tumor tissue, markedly decreased hPD-L1 expression.
M.Wt | 639.97 | |
Formula | C32H32BrClN2O5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Fangfang Lai, et al. Acta Pharm Sin B. 2022 Jun;12(6):2845-2858.
2. Wang Y, et al. Pharmaceutics. 2021 Apr 21;13(5):598.
3. Patent: CN109153670.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright